TITLE

Perspective: Miles to go before we sleep

AUTHOR(S)
Rice, Charles
PUB. DATE
June 2011
SOURCE
Nature;6/9/2011 Supplement, Vol. 474 Issue 7350, pS8
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
In this article, the author discusses the treatment of hepatitis C virus (HCV) infection using the newly developed drugs. He says that the new drugs which are inhibitors of NS3/4A protease must be combined with interferon- and ribavirin because the virus can overcome easily a single antiviral. He also mentions that people in the marginalized groups have higher risk of HCV, in which the availability of new treatment options can widen the gap between those who can afford and those who cannot.
ACCESSION #
61202557

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics